Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome: A scoping review

Publication date

2024-03

Authors

Korteling, Dorinde
Musch, Jiska L.I.
Zinkstok, Janneke R
Boot, Erik

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Smith–Magenis syndrome (SMS) is a neurodevelopmental disorder caused by a 17p11.2 deletion or a pathogenic variant of the RAI1 gene, which lies within the 17p11.2 region. Various psychiatric and neurological disorders have been reported in SMS, with most literature focusing on children and adolescents. To provide an overview of the current knowledge on this topic in adults with SMS, we performed a comprehensive scoping review of the relevant literature. Our findings suggest that many manifestations that are common in childhood persist into adulthood. Neuropsychiatric manifestations in adults with SMS include intellectual disability, autism spectrum- and attention deficit hyperactivity disorder-related features, self-injurious and physical aggressive behaviors, sleep–wake disorders, and seizures. Findings of this review may facilitate optimization of management strategies in adults with SMS, and may guide future studies exploring late-onset psychiatric and neurological comorbidities in SMS.

Keywords

17p11.2, adult, neurology, psychiatry, RAI1, Smith–Magenis syndrome, Genetics(clinical), Psychiatry and Mental health, Cellular and Molecular Neuroscience

Citation

Korteling, D, Musch, J L I, Zinkstok, J R & Boot, E 2024, 'Psychiatric and neurological manifestations in adults with Smith–Magenis syndrome : A scoping review', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 195, no. 2, e32956. https://doi.org/10.1002/ajmg.b.32956